多发性骨髓瘤化疗期间感染病原菌分布及血清β2M、MLR及PLR的检测价值分析OA
Analysis of pathogenic distribution during chemotherapy in multiple myeloma and the diagnostic value of serum β2-microglobulin,monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio
目的 分析多发性骨髓瘤(MM)化疗期间感染患者的病原菌分布及血清β2-微球蛋白(β2M)、单核细胞/淋巴细胞比值(MLR)、血小板/淋巴细胞比值(PLR)对MM化疗期间发生感染的预测价值.方法 采用前瞻性研究方法,选取2021年3月至2024年3月郑州大学附属郑州中心医院收治的MM化疗患者96例,根据住院化疗期间是否发生感染分为感染组42例和非感染组54例.分析感染患者病原菌分布情况,比较感染组与非感染组一般临床资料及β2M、MLR、PLR水平,采用Pearson相关分析β2M水平、MLR、PLR与炎症指标的相关性,采用单因素分析和二元Logistic回归分析MM患者化疗期间发生感染的独立危险因素,采用受试者操作特征(ROC)曲线分析β2M水平、MLR、PLR对MM患者化疗期间发生感染的预测价值.结果 42例感染患者共检出病原菌46株,其中革兰氏阳性菌12株(26.09%),革兰氏阴性菌27株(58.69%),真菌7株(15.22%).感染组国际预后分期系统分期Ⅲ期、肾功能不全、粒细胞减少、血清白蛋白<30 g/L患者占比及白介素-17水平[分别为50.00%、61.90%、45.24%、57.14%、(77.68±9.26)pg/mL]显著高于非感染组[分别为25.93%、31.48%、25.93%、31.48%、(66.45±8.47)pg/mL;χ2/t值分别为6.648、8.843、3.906、6.358、6.186,P<0.05].感染组β2M水平、MLR、PLR显著高于非感染组,差异有统计学意义(P<0.001).Pearson相关分析显示,β2M水平、MLR、PLR与白介素-17呈正相关(r值分别为0.634、0.520、0.438,P<0.05),与血清白蛋白呈负相关(r值分别为-0.551、-0.568、-0.644,P<0.05).二元Logistic回归分析显示,国际预后分期系统分期Ⅲ期,肾功能不全,粒细胞减少,血清白蛋白水平降低,β2M水平、MLR、PLR升高是MM患者化疗期间发生感染的独立危险因素(P<0.05).ROC曲线分析显示,β2M水平、MLR、PLR预测MM患者化疗期间发生感染的曲线下面积分别为0.823、0.809、0.816,联合检测预测MM患者化疗期间发生感染的曲线下面积为0.941,联合检测的曲线下面积显著大于单独检测.结论 MM发生感染患者的血清β2M水平、MLR、PLR异常升高,三者联合检测对于预测MM患者发生感染具有一定应用价值.
Objective To analyze the distribution of pathogenic bacteria in multiple myeloma(MM)patients with infections during chemotherapy and the predictive value of serum β2-microglobulin(β2M),monocyte-to-lymphocyte ratio(MLR)and platelet-to-lymphocyte ratio(PLR)for infection occurrence.Methods A prospective study was conducted on 96 MM patients undergoing chemotherapy at Zhengzhou Central Hospital affiliated to Zhengzhou University from March 2021 to March 2024.Based on the occurrence of infection during hospitalization for chemotherapy,patients were divided into an infection group(n=42)and a non-infection group(n=54).The distribution of pathogenic bacteria in infected patients was analyzed.General clinical data and levels of β2M,MLR and PLR were compared between the two groups.Pearson correlation analysis was used to assess the correlations between β2M/MLR/PLR levels and inflammatory markers.Univariate analysis and binary logistic regression were employed to identify independent risk factors for infection during chemotherapy.Receiver operating characteristic(ROC)curve analysis was performed to evaluate the predictive value of β2M,MLR,and PLR levels for infection occurrence.Results A total of 46 strains of pathogenic bacteria were isolated in 42 infected patients,including 12 strains of Gram-positive bacteria(26.09%),27 strains of Gram-negative bacteria(58.69%)and 7 strains of fungi(15.22%).The proportions of patients with International Staging System(ISS)stage Ⅲ disease,renal insufficiency,granulocytopenia,serum albumin<30 g/L,and the level of interleukin-17(IL-17)[50.00%,61.90%,45.24%,57.14%,and(77.68±9.26)pg/mL,respectively]were significantly higher in the infection group than in the non-infection group[25.93%,31.48%,25.93%,31.48%,and(66.45±8.47)pg/mL,respectively,χ2/t=6.648,8.843,3.906,6.358,6.186,P<0.05].Levels of β2M,MLR and PLR were significantly higher in the infection group than those in the non-infection group(P<0.001).Pearson correlation analysis showed positive correlations between β2M,MLR,PLR levels and IL-17(r=0.634,0.520,0.438,respectively,P<0.05),and negative correlations with serum albumin levels(r=-0.551,-0.568,-0.644,respectively,P<0.05).Binary logistic regression analysis identified ISS stage Ⅲ,renal insufficiency,granulocytopenia,decreased serum albumin levels,and elevated levels of β2M,MLR,and PLR as independent risk factors for infection during MM chemotherapy(P<0.05).ROC curve analysis revealed that the areas under the curve(AUC)for predicting infection using β2M,MLR and PLR alone were 0.823,0.809 and 0.816,respectively.The AUC for their combined detection was 0.941,which was significantly higher than that of any single marker(P<0.05).Conclusions Serum levels of β2M,MLR and PLR are significantly elevated in MM patients with infections.The combined detection of these three markers holds potential application value for predicting infections in MM patients.
周亚方;宋君君;闫春艳
郑州大学附属郑州中心医院血液内科,郑州 450000郑州大学附属郑州中心医院血液内科,郑州 450000郑州大学附属郑州中心医院血液内科,郑州 450000
多发性骨髓瘤化学治疗β2-微球蛋白单核细胞/淋巴细胞比值血小板/淋巴细胞比值
multiple myelomachemotherapyserum β2-microglobulinmonocyte to lymphocyte ratioplatelet-to-lymphocyte ratio
《感染、炎症、修复》 2026 (1)
34-39,6
河南省医学科技攻关计划联合共建项目(LHGJ202107771)
评论